Precigen (PGEN) Non-Current Assets (2012 - 2026)

Precigen's (PGEN) quarterly Non-Current Assets came in at $37.0 million in Q1 2026, down 16.36% year-on-year from $44.2 million in Q1 2025, and down 8.23% on a QoQ basis from $40.3 million in Q4 2025.

Precigen (PGEN) Non-Current Assets (2012 - 2026) Analysis & Trends

Precigen (PGEN) has 15 years of Non-Current Assets data on file, last reported at $37.0 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 16.36% year-over-year to $37.0 million in Q1 2026; TTM through Mar 2026 was $158.0 million, a 14.78% decrease from a year earlier, with the FY2025 full-year figure at $40.3 million, down 6.03% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $37.0 million, down from $40.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for PGEN reached as high as $180.6 million in Q1 2022 and fell as low as $37.0 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $79.2 million across 5 years, with a median of $82.3 million in 2023.
  • Across the five-year window, Non-Current Assets slumped 56.91% in 2022 and grew 1.31% in 2023, its largest moves.
  • Year by year, Non-Current Assets stood at $97.8 million in 2022, then dropped by 15.88% to $82.3 million in 2023, then tumbled by 47.92% to $42.9 million in 2024, then dropped by 6.03% to $40.3 million in 2025, then retreated by 8.23% to $37.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $37.0 million in Q1 2026, $40.3 million in Q4 2025, and $41.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Precigen 1.96 Bn 1.96 Bn 20.69 Mn 36.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 36.96 Mn
Dec 31, 2025 40.27 Mn
Sep 30, 2025 41.67 Mn
Jun 30, 2025 39.14 Mn
Mar 31, 2025 44.19 Mn
Dec 31, 2024 42.85 Mn
Sep 30, 2024 48.96 Mn
Jun 30, 2024 49.45 Mn
Mar 31, 2024 85.30 Mn
Dec 31, 2023 82.29 Mn
Sep 30, 2023 97.70 Mn
Jun 30, 2023 101.90 Mn
Mar 31, 2023 103.80 Mn
Dec 31, 2022 97.82 Mn
Sep 30, 2022 96.44 Mn
Jun 30, 2022 156.61 Mn
Mar 31, 2022 180.63 Mn
Dec 31, 2021 203.23 Mn
Sep 30, 2021 223.81 Mn
Jun 30, 2021 245.89 Mn